Ubicación: Global + English
Global Global Algérie Français Algeria English Angola Português Angola English Argentina Español Argentina English Australia English Austria Deutsch Austria English Azerbaijan English Azerbaijan Русский Bahrain English Bangladesh English Belgium English Belgium Français Belgium Nederlands Brazil Português Brazil English Bulgaria български Bulgaria English Cameroon English Cameroon Français Canada English Canada Français Chile Español Chile English China 中文 China 日本語 China English Colombia Español Colombia English Croatia English Czech Republic Čeština Czech Republic English Denmark English Djibouti English Ecuador Español Ecuador English Egypt English Estonia English Ethiopia English Finland Suomi Finland English France Français France English Georgia English Georgia Русский Germany Deutsch Germany English Ghana English Greece Ελληνικά Greece English Guatemala Español Guatemala English Hong Kong, China English Hong Kong, China 中文 Hungary Magyar Hungary English India English Indonesia English Iraq English Ireland English Italy Italiano Italy English Ivory Coast Français Ivory Coast English Japan 日本語 Japan English Jordan English Kazakhstan Русский Kazakhstan English Kenya English Kuwait English Kyrgyzstan Русский Kyrgyzstan English Latvia English Lithuania English Malaysia English Mauritius English Mauritius français (Maurice) Mexico Español Mexico English Moldova Română Moldova English Mongolia English Morocco English Morocco Français Mozambique Português Mozambique English Netherlands Nederlands Netherlands English New Zealand English Nigeria English Norway English Oman English Pakistan English Paraguay Español Paraguay English Peru Español Peru English Philippines English Poland Polski Poland English Portugal Português Portugal English Qatar English Republic of Korea 한국어 Republic of Korea English Romania Română Romania English Saudi Arabia English Serbia Српски Serbia English Singapore English Slovakia English Slovenia English South Africa English Spain English Spain Español Sri Lanka English Sweden English Switzerland Deutsch Switzerland Français Switzerland Italiano Switzerland English Tanzania English Thailand ไทย Thailand English Togo English Togo Français Tunisia English Tunisia Français Türkiye Türkçe Türkiye English Turkmenistan Русский Turkmenistan English Ukraine Українська Ukraine English United Arab Emirates English United Kingdom English Uruguay Español Uruguay English USA English Uzbekistan English Uzbekistan Русский Vietnam Tiếng Việt Vietnam English

Medical Mask Filtration Efficiency Testing: BFE and PFE Standards, Methods, and Compliance

Medical mask filtration efficiency testing quantifies how effectively surgical and protective masks capture bacterial aerosols and sub-micron particles, and it is a decisive factor in regulatory compliance under standards such as ASTM F2100, EN 14683, GB 19083, and YY 0469. This article explains the core testing items, sample requirements, laboratory methods, and application scenarios for bacterial filtration efficiency (BFE) and particulate filtration efficiency (PFE) evaluation of medical masks, helping manufacturers and regulatory professionals understand what accredited third-party laboratories measure and how results are interpreted.

Technical Overview

Filtration efficiency is the single most important performance indicator for medical masks. It expresses the percentage of challenge particles, whether biological aerosol droplets or sub-micron solid particulates, that are captured by the mask when air is drawn through it under controlled laboratory conditions. The general calculation is: Filtration Efficiency (%) = (Upstream Concentration − Downstream Concentration) / Upstream Concentration × 100.

Two complementary metrics are evaluated. Bacterial filtration efficiency (BFE) assesses performance against aerosolized bacteria with a mean particle size of approximately 3 μm, simulating respiratory droplets generated by coughing or sneezing. Particulate filtration efficiency (PFE) assesses performance against much smaller non-oily or oily particles, typically in the 0.075–0.3 μm range, which represents the most penetrating size for fibrous filter media. Filtration in a melt-blown polypropylene filter layer relies on a combination of mechanisms: inertial impaction, direct interception, Brownian diffusion, and electrostatic attraction from the electret charge applied to the media.

Major standards frameworks include ASTM F2100 in the United States, EN 14683 in Europe, GB 19083 and YY 0469 for medical masks in China, and GB 2626 as a reference method for particulate respirator media. Because filtration results depend heavily on aerosol generation, particle size distribution, and flow control, testing should be performed by accredited third-party laboratories with validated instrumentation.

Testing Samples

Surgical Masks

Surgical masks evaluated under YY 0469, EN 14683, or ASTM F2100 are tested as finished products. Specimens are cut or clamped so that the test aerosol passes through the complete mask structure, typically over a defined test area of approximately 4.9 cm² to 100 cm² depending on the method. A minimum of five specimens per test is customary, and additional specimens should be provided for controls and repeat testing.

Medical Protective Masks

High-performance medical protective masks conforming to GB 19083 are tested for particulate filtration efficiency using the entire mask sealed in a test fixture, with airflow drawn through the media at an elevated flow rate that represents demanding breathing conditions. These products must also satisfy companion requirements such as synthetic blood penetration resistance and fit-related leak testing, but the filtration efficiency value remains the primary classifier of performance grade.

Filter Media and Raw Materials

Melt-blown nonwoven fabric, electret-treated filter layers, and composite laminate materials can be submitted as flat sheet samples for material qualification. Media-level testing is widely used during supplier approval, electret charging process validation, and incoming quality control, because degradation of the electrostatic charge directly reduces filtration efficiency even when the fabric visually appears unchanged.

Testing Items

A filtration efficiency evaluation program for medical masks typically includes the following items:

  • Bacterial filtration efficiency (BFE) against aerosolized Staphylococcus aureus with a mean particle size of approximately 3.0 μm.
  • Particulate filtration efficiency (PFE) for non-oily particles, using sodium chloride aerosol or 0.1 μm polystyrene latex spheres.
  • Filtration efficiency for oily particulates where applicable, using paraffin oil or equivalent aerosols for respirator-grade products.
  • Differential pressure (breathability) testing, which is performed alongside filtration testing because tighter filters that raise efficiency often increase breathing resistance.
  • Synthetic blood penetration resistance and microbial cleanliness, which complete the overall conformity profile of the product standard.

Testing Methods

Bacterial Filtration Efficiency Test

The BFE test is performed per ASTM F2101, EN 14683 Annex B, or the corresponding method in YY 0469. A nebulizer generates an aerosol of Staphylococcus aureus suspension with a controlled mean particle size of approximately 3.0 ± 0.3 μm. Air is drawn through the specimen at a constant flow rate of 28.3 L/min, equivalent to one cubic foot per minute. Bacteria passing through or around the mask are collected on agar plates using a cascade impaction sampler, incubated, and counted as colony forming units.

The efficiency is calculated by comparing the downstream colony count against the upstream challenge control. Because the test involves a viable biological aerosol, it must be conducted in a biosafety containment environment with positive and negative controls run in parallel. Acceptance thresholds are ≥ 95% for EN 14683 Type I, ASTM F2100 Level 1, and YY 0469 surgical masks, and ≥ 98% for EN 14683 Type II and ASTM F2100 Levels 2 and 3.

Particulate Filtration Efficiency Test

For surgical masks under ASTM F2100, PFE is measured per ASTM F2299 using monodisperse polystyrene latex spheres of 0.1 μm diameter. Laser particle counters or condensation particle counters measure upstream and downstream concentrations, and the face velocity is controlled within the range specified by the method. For GB 19083 protective masks and products referencing GB 2626 methodology, a sodium chloride aerosol with a count median diameter of approximately 0.075 μm is delivered at a flow rate of 85 L/min, representing the worst-case penetrating particle size at high work-rate breathing.

YY 0469 surgical masks must achieve at least 30% filtration efficiency for non-oily sodium chloride particles, while GB 19083 medical protective masks must achieve at least 95%. Before testing, aerosol charge is neutralized to a Boltzmann equilibrium using a neutralizer, since unneutralized particles carry electrostatic charge that would artificially inflate results.

Specimen Conditioning and Test Environment

Specimens are typically conditioned at 21 ± 5 °C with relative humidity controlled per the method, commonly 85 ± 5% for at least 4 hours before testing in methods referencing ASTM F2101. Temperature and humidity strongly influence both the electret performance of the filter media and the viability of the bacterial challenge, so environmental monitoring records form part of the test report. Testing equipment, including flow meters, particle counters, and cascade impactors, must be calibrated and verified at defined intervals to ensure traceable and reproducible results.

Applications

Filtration efficiency test reports from accredited third-party laboratories are used across the entire product lifecycle of medical masks:

  • Regulatory registration and market entry, including medical device registration submissions in China, 510(k) premarket notification in the United States, and CE technical documentation under the European medical device regulations.
  • Manufacturer self-declaration support for EN 14683 and ASTM F2100 conformity, where type testing underpins the declaration of performance.
  • Product development and material screening, comparing melt-blown grades, electret treatments, and layer configurations before tooling investment.
  • Incoming inspection and batch release, verifying that purchased filter media retain their declared filtration performance.
  • Post-market surveillance, tender qualification, and export documentation, where buyers and authorities frequently request retesting against the declared standard.

FAQ

What is the difference between BFE and PFE testing?

BFE evaluates capture of bacteria-carrying droplets with a mean particle size of about 3 μm, simulating biological respiratory secretions. PFE evaluates capture of sub-micron solid particles, such as 0.1 μm latex spheres or sodium chloride aerosol, and primarily reflects the mechanical and electrostatic quality of the filter media itself. The two tests are complementary and are both required by the major medical mask standards.

Which filtration requirements apply to each mask class?

Under ASTM F2100, Level 1 masks require BFE and PFE ≥ 95%, while Levels 2 and 3 require ≥ 98%. Under EN 14683, Type I requires BFE ≥ 95% and Type II and Type IIR require ≥ 98%. YY 0469 surgical masks require BFE ≥ 95% and PFE ≥ 30%, while GB 19083 medical protective masks require at least 95% filtration efficiency for non-oily particles.

Does a high BFE result guarantee protection against viruses?

No. BFE is measured with approximately 3 μm droplets, whereas free virions are far smaller. Filtration performance must be considered together with fluid resistance, breathability, and, for respirator-type products, total inward leakage and fit. A high BFE value characterizes the media under the specified test condition and is not a substitute for a full conformity assessment.

Why can filtration results differ between laboratories?

Differences in aerosol generation, particle size distribution verification, charge neutralization, flow stability, specimen sealing in the fixture, and environmental conditioning all influence the outcome. Choosing accredited third-party laboratories with validated methods and calibrated equipment minimizes inter-laboratory variation and ensures the results are accepted by regulators and buyers.

How many samples are needed for a filtration efficiency test?

Most methods require a minimum of five specimens per test condition, plus additional material for challenge controls. For full standard conformity, which includes BFE, PFE, differential pressure, and splash resistance, laboratories typically request a complete test kit of finished masks or media sheets to cover all items and any necessary retests.

How often should filtration efficiency be verified?

Verification frequency should follow the product standard, the quality management system, and risk-based planning. Common practice combines full type testing at design release, periodic verification of filter media at incoming inspection, and confirmatory retesting when materials, suppliers, electret processes, or manufacturing sites change.

Why Choose ZKGX?

  • State-of-the-art analytical equipment
  • Highly qualified scientific team
  • Fast turnaround time
  • Competitive pricing